Korean J Gastroenterol.  2015 Mar;65(3):139-144. 10.4166/kjg.2015.65.3.139.

Quality of Care in Inflammatory Bowel Disease

• Seo GS

• KMID: 2373198
• DOI: http://doi.org/10.4166/kjg.2015.65.3.139

Abstract

Since inflammatory bowel disease (IBD) is a chronic and relapsing disorder, maintaining high quality of care plays an important role in the management of patients with IBD. To develop process-based quality indicator set to improve quality of care, the indicator should be based directly on evidence and consensus. Initially, ImproveCareNow group demonstrated quality improvement by learning how to apply quality improvement methods to improve the care of pediatric patients with IBD. The American Gastroenterological Association has developed adult IBD physician performance measures set and Crohn's and Colitis Foundation of America (CCFA) has developed a set of ten most highly rated process and outcome measures. Recently, The Emerging Practice in IBD Collaborative (EPIC) group generated defining quality indicators for best-practice management of IBD in Canada. Quality of Care through the Patient's Eyes (QUOTE-IBD) was developed as a questionnaire to measure quality of care through the eyes of patients with IBD, and it is widely used in European countries. The current concept of quality of care as well as quality indicator will be discussed in this article.

Keyword

Quality; Care; Indicator; Inflammatory bowel disease

MeSH Terms

Humans
Inflammatory Bowel Diseases/*diagnosis/pathology/therapy
Practice Guidelines as Topic
*Quality Indicators, Health Care
Surveys and Questionnaires

Reference

References

1. Chassin MR, Galvin RW. The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA. 1998; 280:1000–1005.

2. Kohn LT, Corrigan JM, Donaldson MS. Institute of Medicine (US) Committee on Quality of Health Care in America. To err is human: building a safer health system. Washington: National Academy Press;2000.

3. Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington: National Academy Press;2001.

4. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008; 27:759–769.

5. Donabedian A. The quality of care. How can it be assessed? JAMA. 1988; 260:1743–1748.

6. Donabedian A. Quality assessment and monitoring. Retrospect and prospect. Eval Health Prof. 1983; 6:363–375.

7. Cystic Fibrosis Foundation modeling improvement in chronic carebeyond the CF care center. [Accessed 2009 May 7]. Available from:. http://www.kidsquality.org/download.aspx?t=m&id=99.

8. Marshall BC, Penland CM, Hazle L, et al. Cystic fibrosis foundation: achieving the mission. Respir Care. 2009; 54:788–795.

9. Schechter MS, Gutierrez HH. Improving the quality of care for patients with cystic fibrosis. Curr Opin Pediatr. 2010; 22:296–301.

10. O'Connor GT, Plume SK, Olmstead EM, et al. A regional intervention to improve the hospital mortality associated with coro-nary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. JAMA. 1996; 275:841–846.

11. Rejler M, Tholstrup J, Elg M, Spångéus A, Gäre BA. Framework for assessing quality of care for inflammatory bowel disease in Sweden. World J Gastroenterol. 2012; 18:1085–1092.

12. Shah B, Tinsley A, Ullman T. Quality of care in inflammatory bowel disease. Curr Gastroenterol Rep. 2011; 13:87–94.

13. Masachs M, Casellas F, Borruel N, Torrejón A, Castells I, Malagelada JR. Validation of the Spanish version of a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease (QUOTE-IBD). Inflamm Bowel Dis. 2010; 16:982–992.

14. Siegel CA, Melmed GY, Ullman TA. Improving quality of care in IBD: a STEEEP challenge. Inflamm Bowel Dis. 2010; 16:134–136.

15. Kappelman MD, Palmer L, Boyle BM, Rubin DT. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis. 2010; 16:125–133.

16. Boyle BM, Palmer L, Kappelman MD. Quality of health care in the United States: implications for pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009; 49:272–282.

17. Elkjaer M, Moser G, Reinisch W, et al. IBD patients need in health quality of care ECCO consensus. J Crohns Colitis. 2008; 2:181–188.

18. van der Eijk I, Vlachonikolis IG, Munkholm P, et al. EC-IBD Study Group. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis. 2004; 10:392–398.

19. van der Eijk I, Sixma H, Smeets T, European Collaborative Study Group on IBD, et al. Quality of health care in inflammatory bowel disease: development of a reliable questionnaire (QUOTE-IBD) and first results. Am J Gastroenterol. 2001; 96:3329–3336.

20. Standards for the healthcare of people who have inflammatory bowel disease (IBD). [Internet]. [place unknown]: IBD Standards [cited 2012 Jun 13]. Available from:. http://www.ibdstandards.org.uk.

21. Crandall W, Kappelman MD, Colletti RB, et al. ImproveCareNow: the development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis. 2011; 17:450–457.

22. Crandall WV, Margolis PA, Kappelman MD, et al. ImproveCare-Now Collaborative. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics. 2012; 129:e1030–e1041.

23. Melmed GY, Siegel CA, Spiegel BM, et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013; 19:662–668.

24. Swaminath A, Lebwohl B, Capiak KM, Present DH. Practice patterns in the use of anti-tumor necrosis factor alpha agents in the management of Crohn's disease: a US national practice survey comparing experts and non-experts. Dig Dis Sci. 2011; 56:1160–1164.

25. Esrailian E, Spiegel BM, Targownik LE, Dubinsky MC, Targan SR, Gralnek IM. Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes. Aliment Pharmacol Ther. 2007; 26:1005–1018.

26. Spiegel BM, Ho W, Esrailian E, et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol. 2009; 7:168–174.e1.

27. Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol. 2005; 100:1357–1361.

28. Kaplan GG, McCarthy EP, Ayanian JZ, Korzenik J, Hodin R, Sands BE. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology. 2008; 134:680–687.

29. Ananthakrishnan AN, McGinley EL, Binion DG. Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume. Am J Gastroenterol. 2008; 103:2789–2798.

30. MacLean CH, Saag KG, Solomon DH, Morton SC, Sampsel S, Klippel JH. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum. 2004; 51:193–202.

31. Pencharz JN, MacLean CH. Measuring quality in arthritis care: the Arthritis Foundation's Quality Indicator set for osteoarthritis. Arthritis Rheum. 2004; 51:538–548.

32. Adult inflammatory bowel disease physician performance measures set. [Internet]. Bethesda (MD): American Gastroenterological Association [cited 2011 Aug 19]. Available from:. http://www.gastro.org/practice/quality-initiatives/IBD_Measures.pdf.

33. Nguyen GC, Devlin SM, Afif W, et al. Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol. 2014; 28:275–285.

34. Bortoli A, Daperno M, Kohn A, et al. Italian Group for the study of Inflammatory Bowel Disease (IG-IBD). Patient and physician views on the quality of care in inflammatory bowel disease: results from SOLUTION-1, a prospective IG-IBD study. J Crohns Colitis. 2014; 8:1642–1652.

35. Vasudevan A, Arachchi A, van Langenberg DR. Assessing patient satisfaction in inflammatory bowel disease using the QUOTE- IBD survey: a small step for clinicians, a potentially large step for improving quality of care. J Crohns Colitis. 2013; 7:e367–e374.

36. Lehmann M, Walther M, Ulitzsch S, Thomas A, Häuser W, Stallmach A. Validation and first results of the German QUOTE- IBD to measure quality of care from the perspective of patients with inflammatory bowel disease. Z Gastroenterol. 2013; 51:196–203.

37. Pallis AG, Vlachonikolis IG, Mouzas IA. Validation of a reliable in-strument (QUOTE-IBD) for assessing the quality of health care in Greek patients with inflammatory bowel disease. Digestion. 2003; 68:153–160.